Skip to Main Content

Dr. Robert Bona appointed Director of Benign Hematology at Smilow Cancer Hospital

April 27, 2020

Yale Cancer Center (YCC) is pleased to announce the appointment of Robert Bona, M.D., as Professor of Medicine (Hematology) and inaugural Director of the Benign Hematology Program at Smilow Cancer Hospital. He will also join as Medical Director of the Hemophilia Treatment Center for the Pediatric Hematology & Oncology Program at Smilow Cancer Hospital.

Bona has been serving as a part-time member of the hematology department at YCC for the last three years. “We look forward to working more closely with Dr. Bona to build a comprehensive program for patients with inherited and acquired blood diseases,” said Charles Fuchs, M.D., M.P.H., director of YCC and physician-in-chief at Smilow Cancer Hospital.

Bona joins Yale from Quinnipiac University where he is currently a founding faculty member and Professor of Medical Sciences at the Frank H. Netter MD School of Medicine. Previously, he served as the division chief and fellowship program director at the University of Connecticut School of Medicine. He also has strong ties to St. Francis Hospital and Medical Center where he began his career after fellowship. Bona is a leader in the clinical care and research of benign hematological conditions, having led several research studies, clinical trials, and care innovations to advance the treatment of blood diseases.

Bona trained in Hematology-Oncology at the University of Connecticut Health Center, followed by training in clinical thrombosis at McMaster University in Ontario. He graduated from SUNY Upstate Medical University in Syracuse, NY and completed his residency and internship at Brown University.

Bona will start in his new position on July 1.

Submitted by Anne Doerr on April 27, 2020